Auron Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- February 25, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $27,000,000
Company Info
- Company Description
- Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.
- Market
- Oncology and Inflammatory Disease
- Location
- Newton, MA, USA
- Coinvestors
- Apollo Health Ventures, Arkin Bio Ventures, Brightedge, Casdin Capital, DCVC, Franklin Berger, Mubadala Capital, Polaris Partners, Qiming Venture Partners